PHS
UROV

Pekin Hardy Strauss’s Urovant Sciences Ltd. UROV Stock Holding History

Pekin Hardy Strauss’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-26,768
Closed -$432K – 319
2020
Q4 		$432K Sell
26,768
-397,359
-94% -$4.92M 0.08% 188
2020
Q3 		$3.96M Buy
424,127
+37,083
+10% +$329K 0.81% 34
2020
Q2 		$3.81M Buy
387,044
+148,316
+62% +$1.42M 0.84% 32
2020
Q1 		$2.2M Buy
+238,728
New +$2.87M 0.49% 48

Pekin Hardy Strauss's UROV Position: Q1 2021 in Review

Pekin Hardy Strauss sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 26,768 shares — an estimated $432K sold.

Pekin Hardy Strauss first reported a position in UROV in Q1 2020 and held it in 4 quarters. The position peaked at $3.96M in Q3 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

  • Pekin Hardy Strauss reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • Pekin Hardy Strauss sold 26,768 Urovant Sciences Ltd. shares in Q1 2021, an estimated $432K.
  • Pekin Hardy Strauss first reported a position in Urovant Sciences Ltd. in Q1 2020 and held it in 4 quarters.
  • Pekin Hardy Strauss's Urovant Sciences Ltd. position peaked at $3.96M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Pekin Hardy Strauss's 13F filing for Q1 2021, filed 13 May 2021.